Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Gains from Sales and Divestitures (2022 - 2024)

Historic Gains from Sales and Divestitures for OneMedNet (ONMD) over the last 3 years, with Q4 2024 value amounting to $200000.0.

  • OneMedNet's Gains from Sales and Divestitures fell 2478.77% to $200000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $200000.0, marking a year-over-year decrease of 2478.77%. This contributed to the annual value of $200000.0 for FY2024, which is 2478.77% down from last year.
  • According to the latest figures from Q4 2024, OneMedNet's Gains from Sales and Divestitures is $200000.0, which was down 2478.77% from $265914.0 recorded in Q4 2023.
  • OneMedNet's 5-year Gains from Sales and Divestitures high stood at $177.3 million for Q4 2022, and its period low was $200000.0 during Q4 2024.
  • In the last 3 years, OneMedNet's Gains from Sales and Divestitures had a median value of $265914.0 in 2023 and averaged $59.2 million.
  • As far as peak fluctuations go, OneMedNet's Gains from Sales and Divestitures crashed by 9985.0% in 2023, and later plummeted by 2478.77% in 2024.
  • Over the past 3 years, OneMedNet's Gains from Sales and Divestitures (Quarter) stood at $177.3 million in 2022, then crashed by 99.85% to $265914.0 in 2023, then fell by 24.79% to $200000.0 in 2024.
  • Its last three reported values are $200000.0 in Q4 2024, $265914.0 for Q4 2023, and $177.3 million during Q4 2022.